CC BY-NC-ND 4.0 · Laryngo-Rhino-Otol 2018; 97(S 01): S3-S47
DOI: 10.1055/s-0043-121594
Referat
Eigentümer und Copyright ©Georg Thieme Verlag KG 2018

Immunotherapy – The New Era of Oncology

Artikel in mehreren Sprachen: deutsch | English
Benjamin Kansy
1  Klinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie, Universitätsklinikum Essen, Universität Duisburg-Essen
,
Stephan Lang
1  Klinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie, Universitätsklinikum Essen, Universität Duisburg-Essen
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
22. März 2018 (online)

  

Abstract

In the field of immunotherapy, essential progress was achieved over the past years partially demonstrating long lasting therapeutic responses in different tumor entities. A better understanding of the interactions between the tumor and the immune system as well as the integration of immunotherapeutic approaches into clinical routine were the foundations for this development. The different approaches intervene on multiple levels of the immune response and directly or indirectly mount the patient‘s own immune defense against tumor cells. Immunotherapeutic approaches are represented by cytokine therapies, vaccinations, the use of oncolytic viruses and monoclonal antibody therapies as well as adoptive cell transfer strategies.